Detalhe da pesquisa
1.
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
J Hepatol
; 80(3): 419-430, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37984709
2.
Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt.
J Viral Hepat
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38622910
3.
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™.
J Viral Hepat
; 30(4): 335-344, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601668
4.
Serum Biomarkers are Associated With Atherosclerotic Cardiovascular Disease Among Patients With Nonalcoholic Fatty Liver Disease Undergoing Elective Angiography.
Clin Gastroenterol Hepatol
; 20(5): e1149-e1156, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34464720
5.
Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis.
Clin Gastroenterol Hepatol
; 20(9): 2050-2058.e12, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34274514
6.
Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response.
Clin Gastroenterol Hepatol
; 20(2): 438-446, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493697
7.
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry.
J Viral Hepat
; 29(11): 1015-1025, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36036096
8.
The impact of fatigue on mortality of patients with non-alcoholic fatty liver disease: Data from National Health and nutrition examination survey 2005-2010 and 2017-2018.
Liver Int
; 42(12): 2646-2661, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36161464
9.
Long-term Benefits of Sustained Virologic Response for Patient-Reported Outcomes in Patients With Chronic Hepatitis C Virus Infection.
Clin Gastroenterol Hepatol
; 18(2): 468-476.e11, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31376493
10.
Primary Biliary Cholangitis in Medicare Population: The Impact on Mortality and Resource Use.
Hepatology
; 69(1): 237-244, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30015376
11.
Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States.
Hepatology
; 69(2): 564-572, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30180285
12.
Hypothetical treatment of patients with non-alcoholic steatohepatitis: Potential impact on important clinical outcomes.
Liver Int
; 40(2): 308-318, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31705834
13.
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.
J Hepatol
; 71(4): 793-801, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31279902
14.
Long-term Effects of Treatment for Chronic HBV Infection on Patient-Reported Outcomes.
Clin Gastroenterol Hepatol
; 17(8): 1641-1642.e1, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30268565
15.
Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.
Clin Gastroenterol Hepatol
; 17(8): 1625-1633.e1, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30476585
16.
Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life.
Am J Gastroenterol
; 114(10): 1636-1641, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31464743
17.
Development and validation of a primary sclerosing cholangitis-specific patient-reported outcomes instrument: The PSC PRO.
Hepatology
; 68(1): 155-165, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29152767
18.
Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication.
Liver Int
; 39(10): 1837-1844, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31173468
19.
Factors Associated With Potential Progressive Course of Primary Biliary Cholangitis: Data From Real-world US Database.
J Clin Gastroenterol
; 53(9): 693-698, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30148766
20.
Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study.
Qual Life Res
; 27(6): 1513-1520, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29460201